Neutrophil-to-Lymphocyte Ratio Can Distinguish Patients with Liver Cirrhosis from Healthy People but Cannot Distinguish Patients with Cirrhotic Hepatocellular Carcinoma from Patients with Liver Cirrhosis

PURPOSE: Identifying cirrhotic hepatocellular carcinoma (HCC) during liver cirrhosis (LC) stage is pivotal for improving the clinical outcomes of cirrhotic HCC patients. Inflammation-driven markers play a crucial role in tumorigenesis and tumor progression. Neutrophil-to-lymphocyte ratio (NLR) is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xuming, Zhou, Hongxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628700/
https://www.ncbi.nlm.nih.gov/pubmed/36338430
http://dx.doi.org/10.2147/JHC.S387189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628700/
https://www.ncbi.nlm.nih.gov/pubmed/36338430
http://dx.doi.org/10.2147/JHC.S387189

Ejemplares similares